Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 5-year average of -9.03%, near the high end of its 5-year range (-106.97%–12.96%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
-12.28%
OPERATING MARGIN AVG 5Y
-9.03%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$89.44M
Operating Margin
-37.64%
TTM Avg
-44.68%
3Y Avg
-118.22%
5Y Avg
-258.09%
Market Cap
$90.20M
Operating Margin
12.60%
TTM Avg
-0.11%
3Y Avg
-11.38%
5Y Avg
-8.86%
Market Cap
$90.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$90.64M
Operating Margin
-3270.86%
TTM Avg
-6391.41%
3Y Avg
-3195.70%
5Y Avg
-2130.47%
Market Cap
$87.85M
Operating Margin
29.69%
TTM Avg
-17.51%
3Y Avg
-923.94%
5Y Avg
-894.93%
Market Cap
$87.27M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$92.69M
Operating Margin
-2.82%
TTM Avg
2.49%
3Y Avg
2.00%
5Y Avg
2.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Equillium, Inc. (EQ) | $89.78M | 0.00% | 0.00% | -12.28% | -9.03% |
| electroCore, Inc. (ECOR)vs › | $89.44M | -37.64% | -44.68% | -118.22% | -258.09% |
| ImmuCell Corporation (ICCC)vs › | $90.20M | 12.60% | -0.11% | -11.38% | -8.86% |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rallybio Corporation (RLYB)vs › | $90.64M | -3270.86% | -6391.41% | -3195.70% | -2130.47% |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 7.31% | 8.88% | -4.43% | -3.84% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $87.85M | 29.69% | -17.51% | -923.94% | -894.93% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $87.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $92.69M | -2.82% | 2.49% | 2.00% | 2.00% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $85.86M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -106.97% |
| 2024-09-30 | -5.58% |
| 2024-06-30 | -0.72% |
| 2024-03-31 | -26.11% |
| 2023-12-31 | -34.74% |
| 2023-09-30 | -40.85% |
| 2023-06-30 | -39.36% |
| 2023-03-31 | -46.27% |
| 2022-12-31 | 12.96% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
